{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:26:17Z","timestamp":1778671577268,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T00:00:00Z","timestamp":1456272000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"name":"George E. and Ruth Moss Trust"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00417-016-3305-2","type":"journal-article","created":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T21:46:18Z","timestamp":1456263978000},"page":"1371-1378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Tumor-height regression rate after brachytherapy between choroidal melanoma gene expression profile classes: effect of controlling for tumor height"],"prefix":"10.1007","volume":"254","author":[{"given":"Kishan","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin A.","family":"McCannel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell","family":"Kamrava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Almanzor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara A.","family":"McCannel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,24]]},"reference":[{"key":"3305_CR1","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","volume":"118","author":"AD Singh","year":"2011","unstructured":"Singh AD, Turell ME, Topham AK (2011) Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology 118:1881\u20131885. doi: 10.1016\/j.ophtha.2011.01.040","journal-title":"Ophthalmology"},{"key":"3305_CR2","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0161-6420(87)33310-X","volume":"94","author":"JJ Augsburger","year":"1987","unstructured":"Augsburger JJ, Gamel JW, Shields JA et al (1987) Post-irradiation regression of choroidal melanomas as a risk factor for death from metastatic disease. Ophthalmology 94:1173\u20131177. doi: 10.1016\/S0161-6420(87)33310-X","journal-title":"Ophthalmology"},{"key":"3305_CR3","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/S0161-6420(89)32685-6","volume":"96","author":"RJ Glynn","year":"1989","unstructured":"Glynn RJ, Seddon JM, Gragoudas ES et al (1989) Evaluation of tumor regression and other prognostic factors for early and late metastasis after proton irradiation of UVeal melanoma. Ophthalmology 96:1566\u20131573. doi: 10.1016\/S0161-6420(89)32685-6","journal-title":"Ophthalmology"},{"key":"3305_CR4","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1136\/bjo.2003.036285","volume":"88","author":"I Kaiserman","year":"2004","unstructured":"Kaiserman I, Anteby I, Chowers I et al (2004) Post-brachytherapy initial tumour regression rate correlates with metastatic spread in posterior uveal melanoma. Br J Ophthalmol 88:892\u2013895. doi: 10.1136\/bjo.2003.036285","journal-title":"Br J Ophthalmol"},{"key":"3305_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1055\/s-2008-1046119","volume":"196","author":"R Guthoff","year":"1990","unstructured":"Guthoff R, Haase J, von Domarus D et al (1990) The regression behavior of choroid melanoma following radiotherapy\u2014a new prognostic parameter? Klin Monbl Augenheilkd 196:6\u201310. doi: 10.1055\/s-2008-1046119","journal-title":"Klin Monbl Augenheilkd"},{"key":"3305_CR6","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","volume":"124","author":"N Authors","year":"2006","unstructured":"Authors N (2006) The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. Arch Ophthalmol 124:1684. doi: 10.1001\/archopht.124.12.1684","journal-title":"Arch Ophthalmol"},{"key":"3305_CR7","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(96)90736-9","volume":"347","author":"G Prescher","year":"1996","unstructured":"Prescher G, Bornfeld N, Hirche H et al (1996) Prognostic implications of monosomy 3 in uveal melanoma. Lancet 347:1222\u20131225","journal-title":"Lancet"},{"key":"3305_CR8","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.ophtha.2007.06.012","volume":"114","author":"B Damato","year":"2007","unstructured":"Damato B, Duke C, Coupland SE et al (2007) Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology 114:1925\u20131931. doi: 10.1016\/j.ophtha.2007.06.012","journal-title":"Ophthalmology"},{"key":"3305_CR9","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1136\/bjophthalmol-2014-305047","volume":"98","author":"TH Essen Van","year":"2014","unstructured":"Van Essen TH, van Pelt SI, Versluis M et al (2014) Prognostic parameters in uveal melanoma and their association with BAP1 expression. Br J Ophthalmol 98:1738\u20131743. doi: 10.1136\/bjophthalmol-2014-305047","journal-title":"Br J Ophthalmol"},{"key":"3305_CR10","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1167\/iovs.11-8697","volume":"53","author":"T Bosch Van den","year":"2012","unstructured":"Van den Bosch T, van Beek JGM, Vaarwater J et al (2012) Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis. Invest Ophthalmol Vis Sci 53:2668\u20132674. doi: 10.1167\/iovs.11-8697","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3305_CR11","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.ophtha.2012.02.017","volume":"119","author":"MD Onken","year":"2012","unstructured":"Onken MD, Worley LA, Char DH et al (2012) Collaborative ocular oncology group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology 119:1596\u20131603. doi: 10.1016\/j.ophtha.2012.02.017","journal-title":"Ophthalmology"},{"key":"3305_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/currents.eogt.af8ba80fc776c8f1ce8f5dc485d4a618","volume":"12597007","author":"JW Harbour","year":"2013","unstructured":"Harbour JW, Chen R (2013) The decisiondx-UM gene expression profile test provides risk stratification and individualized patient care in uveal melanoma. PLoS Curr 12597007:1\u201310. doi: 10.1371\/currents.eogt.af8ba80fc776c8f1ce8f5dc485d4a618","journal-title":"PLoS Curr"},{"key":"3305_CR13","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1001\/archophthalmol.2009.151","volume":"127","author":"CL Shields","year":"2009","unstructured":"Shields CL, Furuta M, Berman EL et al (2009) Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases. Arch Ophthalmol 127:981\u2013987. doi: 10.1001\/archophthalmol.2009.151","journal-title":"Arch Ophthalmol"},{"key":"3305_CR14","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.ijrobp.2010.07.016","volume":"81","author":"OS Marathe","year":"2011","unstructured":"Marathe OS, Wu J, Lee SP et al (2011) Ocular response of choroidal melanoma with monosomy 3 versus disomy 3 after iodine-125 brachytherapy. Int J Radiat Oncol Biol Phys 81:1046\u20131048. doi: 10.1016\/j.ijrobp.2010.07.016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3305_CR15","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/bjophthalmol-2013-304472","volume":"98","author":"PJT Chiam","year":"2014","unstructured":"Chiam PJT, Coupland SE, Kalirai H et al (2014) Does choroidal melanoma regression correlate with chromosome 3 loss after ruthenium brachytherapy? Br J Ophthalmol 98:967\u2013971. doi: 10.1136\/bjophthalmol-2013-304472","journal-title":"Br J Ophthalmol"},{"key":"3305_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3928\/23258160-20150323-06","volume":"46","author":"RC Rao","year":"2015","unstructured":"Rao RC, Khan M, Badiyan SN, Harbour JW (2015) Gene expression profiling and regression rate of irradiated uveal melanomas. Ophthalmic Surg Lasers Imaging Retina 46:333\u2013337. doi: 10.3928\/23258160-20150323-06","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"3305_CR17","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1007\/s00417-014-2793-1","volume":"252","author":"RWS Chen","year":"2014","unstructured":"Chen RWS, Harbour JW (2014) Rapid regression of a subset of class 1 uveal melanomas after Iodine-125 plaque radiotherapy suggests an inflammatory mechanism. Graefes Arch Clin Exp Ophthalmol 252:2021\u20132022. doi: 10.1007\/s00417-014-2793-1","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3305_CR18","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1167\/iovs.13-13381","volume":"55","author":"ZM Corr\u00eaa","year":"2014","unstructured":"Corr\u00eaa ZM, Augsburger JJ (2014) Relationship between rate of posterior uveal melanoma flattening following plaque radiotherapy and gene expression profile class of tumor cells. Invest Ophthalmol Vis Sci 55:556\u2013559. doi: 10.1167\/iovs.13-13381","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3305_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4103\/0974-9233.148358","volume":"22","author":"H Demirci","year":"2015","unstructured":"Demirci H, Saponara F, Khan A et al (2015) Regression rate of posterior uveal melanomas following iodine-125 plaque radiotherapy. Middle East Afr J Ophthalmol 22:103. doi: 10.4103\/0974-9233.148358","journal-title":"Middle East Afr J Ophthalmol"},{"key":"3305_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ajo.2012.02.022","volume":"154","author":"MC Chappell","year":"2012","unstructured":"Chappell MC, Char DH, Cole TB et al (2012) Uveal melanoma: molecular pattern, clinical features, and radiation response. Am J Ophthalmol 154:227\u2013232. doi: 10.1016\/j.ajo.2012.02.022","journal-title":"Am J Ophthalmol"},{"key":"3305_CR21","first-page":"43","volume":"105","author":"CL Shields","year":"2007","unstructured":"Shields CL, Ganguly A, Materin MA et al (2007) Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases. Trans Am Ophthalmol Soc 105:43\u201352, discussion 52\u20133","journal-title":"Trans Am Ophthalmol Soc"},{"key":"3305_CR22","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2353\/jmoldx.2006.060077","volume":"8","author":"MD Onken","year":"2006","unstructured":"Onken MD, Worley LA, D\u00e1vila RM et al (2006) Prognostic testing in uveal melanoma by transcriptomic profiling of fine-needle biopsy specimens. J Mol Diagn 8:567\u2013573. doi: 10.2353\/jmoldx.2006.060077","journal-title":"J Mol Diagn"},{"key":"3305_CR23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000326153","volume":"49","author":"BE Faulkner-Jones","year":"2005","unstructured":"Faulkner-Jones BE, Foster WJ, Harbour JW et al (2005) Fine needle aspiration biopsy with adjunct immunohistochemistry in intraocular tumor management. Acta Cytol 49:297\u2013308","journal-title":"Acta Cytol"},{"key":"3305_CR24","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ophtha.2011.08.046","volume":"119","author":"TA McCannel","year":"2012","unstructured":"McCannel TA, Chang MY, Burgess BL (2012) Multi-year follow-up of fine-needle aspiration biopsy in choroidal melanoma. Ophthalmology 119:606\u2013610. doi: 10.1016\/j.ophtha.2011.08.046","journal-title":"Ophthalmology"},{"key":"3305_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brachy.2013.11.008","volume":"13","author":"ER Simpson","year":"2014","unstructured":"Simpson ER, Gallie B, Laperrierre N et al (2014) The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma. Brachytherapy 13:1\u201314. doi: 10.1016\/j.brachy.2013.11.008","journal-title":"Brachytherapy"},{"key":"3305_CR26","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/S0161-6420(84)34087-8","volume":"91","author":"AF Cruess","year":"1984","unstructured":"Cruess AF, Augsburger JJ, Shields JA et al (1984) Regression of posterior uveal melanomas following cobalt-60 plaque radiotherapy. Ophthalmology 91:1716\u20131719","journal-title":"Ophthalmology"},{"key":"3305_CR27","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-16322","author":"M Rashid","year":"2015","unstructured":"Rashid M, Heikkonen J, Kivel\u00e4 T (2015) Tumor regression after brachytherapy for choroidal melanoma: reduction of thickness and cross-sectional area by shape and regression pattern. Invest Ophthalmol Vis Sci. doi: 10.1167\/iovs.14-16322","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3305-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-016-3305-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3305-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:40:58Z","timestamp":1559058058000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-016-3305-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,24]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["3305"],"URL":"https:\/\/doi.org\/10.1007\/s00417-016-3305-2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726174282.793544687","asserted-by":"object"}]},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,24]]}}}